Potassium Magnesium Aspartate Glucose Injection

Potassium magnesium aspartate is a mixture of potassium aspartate and magnesium salts and is an electrolyte supplement. Magnesium and potassium are important cations in cells and play an important role in a variety of enzyme reactions and muscle contraction. The ratio of potassium ion, calcium ion, sodium ion and magnesium ion concentration inside and outside cells affects myocardial contractility. Aspartic acid is a precursor of oxaloacetate in the body and plays an important role in the tricarboxylic acid cycle. At the same time, aspartic acid also participates in the ornithine cycle, promoting the metabolism of ammonia and carbon dioxide to produce urea and reduce the content of ammonia and carbon dioxide in the blood. Aspartic acid has a strong affinity with cells and can serve as a carrier for potassium and magnesium ions to enter cells, allowing potassium ions to return to cells, promoting cell depolarization and cell metabolism, and maintaining their normal functions; magnesium ions are an indispensable substance for the production of glycogen and high-energy phosphates.

This product is a compound preparation, and its components are: each 1 ml contains 7.90~9.10 mg of L-aspartic acid (C4H7NO4), 1.06~1.22 mg of potassium (K), 0.39~0.45 mg of magnesium (Mg), and 47.5~52.5 mg of glucose (C6H12O6·H2O).

This product is a colorless clear liquid.

Electrolyte supplement. It can be used as an adjuvant treatment for hypokalemia, arrhythmias (mainly ventricular arrhythmias) caused by digitalis poisoning, and sequelae of myocarditis, congestive heart failure, and myocardial infarction.

Intravenous drip: 100ml~200ml each time, slowly intravenously drip, once a day, or as directed by your doctor.

Too fast an infusion rate may cause hyperkalemia and hypermagnesemia, and may also cause nausea, vomiting, facial flushing, chest tightness, decreased blood pressure, and occasionally vascular irritation pain. Large doses may cause diarrhea.

It is contraindicated in patients with hyperkalemia, acute and chronic renal failure, Addison's disease, Ⅲo atrioventricular block, and cardiogenic shock (blood pressure below 90 mmHg).

Hyperkalemia may occur when this product is used in combination with potassium-sparing diuretics and/or angiotensin-converting enzyme inhibitors (ACEI).

Keep in a dark place and sealed. The validity period is tentatively set at one year.

250ml: L-aspartic acid 0.85g, potassium 0.114g, magnesium 0.042g, glucose 12.5g

Huaren Pharmaceutical Co., Ltd.

• Founded in:

  1998-05-20

• Address:

  No. 187, Zhuzhou Road, Qingdao High-tech Industrial Park

• Tax NO.:

  91370200706426601X

• Registered Funds:

  1,182,212,982 yuan

• Website:

  Log in to view

• Email:

  Log in to view